These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38638511)

  • 21. Hope in palliative care: from narcissism to self-transcendence in amyotrophic lateral sclerosis.
    Fanos JH; Gelinas DF; Foster RS; Postone N; Miller RG
    J Palliat Med; 2008 Apr; 11(3):470-5. PubMed ID: 18363490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of coping strategies in MND/ALS: Association with demographic and disease-related characteristics.
    Schlüter DK; Holland DP; Mills RJ; McDermott CJ; Williams TL; Young CA;
    Acta Neurol Scand; 2019 Aug; 140(2):131-139. PubMed ID: 31058309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
    Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
    Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
    Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
    Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis.
    Sandstedt P; Johansson S; Ytterberg C; Ingre C; Holmqvist LW; Kierkegaard M
    J Neurol Sci; 2016 Nov; 370():269-273. PubMed ID: 27772773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease.
    Mukherjee N; McBurney-Lin S; Kuo A; Bedlack R; Tseng H
    PLoS One; 2017; 12(9):e0185242. PubMed ID: 28945811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.
    Burke T; Hardiman O; Pinto-Grau M; Lonergan K; Heverin M; Tobin K; Staines A; Galvin M; Pender N
    J Neurol; 2018 Apr; 265(4):793-808. PubMed ID: 29396678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study.
    Okhovat AA; Fatehi F; Rafiemehr M; Moradi K; Kiani-Mehr G; Nafissi S
    Curr J Neurol; 2020 Oct; 19(4):190-195. PubMed ID: 38011396
    [No Abstract]   [Full Text] [Related]  

  • 30. Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).
    Koç F; Balal M; Demir T; Alparslan ZN; Sarica Y
    Noro Psikiyatr Ars; 2016 Sep; 53(3):229-233. PubMed ID: 28373799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease.
    Cui F; Zhu W; Zhou Z; Ren Y; Li Y; Li M; Huo Y; Huang X
    Neuropsychiatr Dis Treat; 2015; 11():2847-54. PubMed ID: 26604769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival.
    Burke T; Galvin M; Pinto-Grau M; Lonergan K; Madden C; Mays I; Carney S; Hardiman O; Pender N
    J Neurol; 2017 May; 264(5):898-904. PubMed ID: 28280986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients' self-perceived burden, caregivers' burden and quality of life for amyotrophic lateral sclerosis patients: a cross-sectional study.
    Geng D; Ou R; Miao X; Zhao L; Wei Q; Chen X; Liang Y; Shang H; Yang R
    J Clin Nurs; 2017 Oct; 26(19-20):3188-3199. PubMed ID: 27874996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
    Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
    Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
    Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options.
    Trail M; Nelson ND; Van JN; Appel SH; Lai EC
    J Neurol Sci; 2003 May; 209(1-2):79-85. PubMed ID: 12686407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.
    Kwan JY; Meoded A; Danielian LE; Wu T; Floeter MK
    Neuroimage Clin; 2012; 2():151-60. PubMed ID: 24179768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
    Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
    Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.